T A B L E O F C O N T E N T S

Main results
We identified no new studies for this third update. The review includes five studies involving 3082 participants comparing plastic adhesive drapes with no drapes and two studies involving 1113 participants comparing iodine-impregnated adhesive drapes with no drapes. A significantly higher proportion of patients in the adhesive drape group developed a surgical site infection when compared with no drapes (risk ratio (RR) 1.23, 95% confidence interval (CI) 1.02 to 1.48, P = 0.03). Iodine-impregnated adhesive drapes had no effect on the surgical site infection rate (RR 1.03, 95% CI 0.06 to 1.66, P = 0.89). Length of hospital stay was similar in the adhesive drape and non-adhesive drape groups.
Authors' conclusions
There was no evidence from the seven trials that plastic adhesive drapes reduce surgical site infection rates, and some evidence that they increase infection rates. Further trials may be justified, using blinded outcome assessment to examine the effect of adhesive drapes on surgical site infection, based on different wound classifications.
P L A I N L A N G U A G E S U M M A R Y
Use of plastic adhesive drapes during surgery for preventing surgical site infection
Following surgery, up to 30% of wounds may become infected. This complication of surgery may cause distress for the patient and lead to higher treatment costs. Many interventions have been designed to reduce postoperative infections. One of these is the use of a drape which adheres to the skin, and through which the surgeon cuts. It is thought that adhesive drapes prevent germs (which may be on the skin) from entering the open wound. This updated review of over 4000 patients, in seven separate trials could find no evidence that adhesive drapes reduce surgical site infection rates, and some evidence that they may increase infection rates.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Adhesive drapes compared with no adhesive drapes for preventing surgical site infection *The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI). CI: Confidence interval; RR: Risk ratio GRADE Working Group grades of evidence High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality:
We are very uncertain about the estimate.
B A C K G R O U N D
Description of the condition
Surgical site infection (SSI) is one of the most common postoperative complications, and has been estimated to occur in about 15% of cases of clean surgery and 30% of contaminated surgery cases (Bruce 2001) . SSI is associated with longer recovery and further risks of additional complications, therefore increasing the risk of morbidity and mortality (Mangram 1999) . However the incidence rate depends on a number of factors, including the definition of infection used, the intensity of surveillance, whether patients are followed up after discharge, and the prevalence of risk factors in the population studied (Smyth 2000) . Risk factors associated with SSI have been grouped into two main categories: patient-or host-related and operation-or procedure-related (Mangram 1999; Smyth 2000) . Patient characteristics include age, obesity, co morbidities such as diabetes, remote infection, American Society of Anestheologists score (ASA) status, immunosuppressive therapy and length of preoperative hospital stay. Operative risk factors include length of surgery, skin preparation (including shaving and antiseptic skin preparation), type of procedure, antimicrobial prophylaxis and surgical technique (Mangram 1999; Smyth 2000) . Surgical wounds are frequently classified as either 'clean', 'clean contaminated', 'contaminated' or 'dirty-infected' with the latter categories associated with a higher infection rate (Lilani 2005) .
Many countries now benchmark their SSI rate using the National Nosocomial Infections Surveillance (NNIS) system risk index, in which wound classification is combined with the ASA status, length of surgery and whether surgery was undertaken laparoscopically to assess risk of SSI (Gaynes 2001) . The additional per patient cost of SSI has been estimated to be between GBP 959 for abdominal hysterectomy to GBP 6103 for limb amputation (Coello 2005) , and over USD 14,000 for an organ space SSI (Kashimura 2012). In the Unites States the estimated annual cost of SSIs is USD 3.5 billion to USD 10 billion (Thompson 2011) .
Description of the intervention
The high additional costs associated with SSI have led to the adoption of strategies that could reduce the incidence of SSI. These strategies include administration of prophylactic antibiotics, use of antiseptic solutions for skin preparation, and the use of sterile disposable materials. One of the commonly used operative strategies to reduce SSI is the plastic adhesive drape (referred to hereafter as adhesive drape). This was first tested 50 years ago on a cohort of patients undergoing a range of abdominal surgeries (Payne 1956 ).
The study had three main aims: 1) to test adherence of a polyvinyl drape to the skin; 2) to assess the level of wound contamination; and 3) to assess skin and wound reaction to the drape. Problems were found with adherence of the drape to the skin, despite trialing a number of skin preparation solutions. Positive cultures were recovered from two of the 51 wounds but no skin or wound reactions to the polyvinyl sheet were recorded. Since that time, use of adhesive drapes has become widespread and the product has undergone modifications to improve effectiveness (Ritter 1988; Yoshimura 2003) . This review will focus on plastic (defined as polyethylene, polyurethane or polyvinyl) adhesive drapes (e.g. Op-Site (Smith and Nephew), Ioban (3M Company, USA), Steridrape (3M United Kingdom) through which an incision is made. Drapes may be either plain or impregnated with an antibacterial agent such as iodine.
How the intervention might work
For most SSIs, the source of the invading pathogen (or disease causing biological agent) is the patient's skin (Nichols 1996) . Consequently, preoperative skin preparation is intended to render the skin as free as possible from bacteria that may enter the surgical wound. Although skin disinfection prior to surgery drastically reduces the number of bacteria on the skin's surface, recolonisation with bacteria from deeper skin layers and hair follicles may occur during the operation (Fleischmann 1996) . Sterile surgical drapes, made of either linen or impervious paper, are used to prevent any contact with unprepared surfaces. Adhesive drapes are also used for this purpose and, are generally used in combination with other draping techniques, but they have an additional function; theoretically, they act as a microbial barrier, to prevent migration of contaminating bacteria from the skin to the operative site, for which there is some evidence (French 1976; Ha'eri 1983) .
Why it is important to do this review
Although there is theoretical plausibility for the use of adhesive drapes, conflicting reports have been published regarding their usefulness in limiting bacteria around the surgical site (Katthagen 1992; Lilly 1970) and for preventing SSI (Ritter 1988; Swenson 2008) . Recolonisation of the skin following antiseptic preparation is also more rapid under adhesive drapes compared with using no adhesive drapes (Falk-Brynhildsen 2012). Moreover, allergic reactions to povidone iodine are not unknown, and there is at least one case report of allergic contact dermatitis associated with the use of iodophor-impregnated incise drapes (Zokaie 2011). In a related systematic review, Edwards 2009 found no benefit in using iodophor-impregnated adhesive drapes to prevent postoperative surgical wound infection, when they were used as part of preoperative skin antisepsis. In light of these controversies, and because their use is widespread, a systematic review of the possible benefits and harms of adhesive drapes is justified to guide clinical practice.
O B J E C T I V E S
The primary objective of this systematic review was to assess the effect of plastic adhesive drapes used during surgery on surgical site infection (SSI) rates.
The secondary objectives were:
1. to determine the cost effectiveness of using plastic adhesive drapes;
2. to assess if there were any adverse effects associated with the use of plastic adhesive drapes; and 3. to determine whether different types of plastic adhesive drapes (polyethylene/polyurethane/polyvinyl) have differential effects on SSI rates.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) that evaluated the effectiveness of adhesive drapes (used alone or in combination with other drapes), in preventing SSI.
Types of participants
We considered for inclusion, trials recruiting people of any age or gender, undergoing any type of inpatient or outpatient surgery.
Types of interventions
The primary intervention was adhesive drapes (polyethylene, polyurethane or polyvinyl), through which an incision is made. Adhesive drapes may have been used alone or in combination with other drapes: woven (material) drapes or disposable (paper) drapes and with any antiseptic skin preparation. The comparison intervention was no adhesive drapes; other drapes such as woven (material) drapes or disposable (paper) drapes may have been used. We excluded trials evaluating plastic 'ring drapes' or 'V' drapes as the incision is not made through the drape. Comparisons included:
• adhesive drapes (without added antimicrobial properties) compared with no adhesive drapes; and
• adhesive drapes (with added antimicrobial properties) compared with no adhesive drapes.
Types of outcome measures
Primary outcomes
Rates of surgical site infection (SSI). For the purposes of this review we accepted the definition of SSI used in the trial. 
Search methods for identification of studies
Electronic searches
For an outline of the search methods used in the second update of this review see Appendix 1.
For this third update we modified the search strategy and ran it over all available years in the following electronic databases.
• The Cochrane Wounds Group Specialised Register (searched 19 July, 2012).
• The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 7).
• Ovid MEDLINE (1946 to July Week 2 2012).
• Ovid MEDLINE (In-Process & Other Non-Indexed Citations, July 18, 2012).
• Ovid EMBASE (1974 ( to Week 28, 2012 We did not apply any date or language restrictions.
Searching other resources
We contacted researchers and manufactures in order to obtain any unpublished data. We also searched reference lists of potentially useful articles.
Data collection and analysis
Selection of studies
For the initial review, two authors (JW, AA) independently assessed the title and abstracts of references identified by the search strategy. We then retrieved full reports of all potentially relevant trials for further assessment of eligibility, based on the inclusion criteria. We settled differences of opinion by consensus or referral to the editorial base of the Wounds Group. There was no blinding of authorship. For this updated review, JW excluded trials and the Managing Editor of the Wounds Group verified their exclusion.
Data extraction and management
Two review authors (JW,AA) independently extracted the following data, using a piloted data extraction sheet: type of study, country, study setting, number of participants, sex, mean age, type of surgery, preoperative wound classification, predisposing risk factors by treatment groups, type of drape, draping procedure, type of preoperative skin preparation, prophylactic or therapeutic antibiotic use, all primary and secondary outcome measures reported and authors' conclusions. Clarification about aspects of the trial were required from all of the authors; five were untraceable (Chiu 1993; Cordtz 1989; Jackson 1971; Psaila 1977; Ward 2001) . Additional trial details were received from Dewan 1987 and from the second author of the Segal 2002 trial. We also contacted manufacturers of plastic adhesive drapes (Johnson & Johnson, 3M Company and Smith & Nephew) to request details of any unpublished trials. A representative of each of these manufacturers responded; no current trials are underway and they were unaware of any unpublished trials.
Assessment of risk of bias in included studies
Two review authors independently assessed the quality of eligible trials, using a predefined quality assessment form, based on the assessment criteria outlined below. Disagreements between review authors were again resolved by consensus or referral to the editorial base of the Wounds Group. We contacted investigators of included trials to resolve any ambiguities. For this update, each included study was assessed using the Cochrane Collaboration's tool for assessing risk of bias (Higgins 2011). This tool addresses six specific domains, namely sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting, and other issues (e.g. extreme baseline imbalance) (see Appendix 5 for details of criteria on which the judgement was based). We assessed blinding and completeness of outcome data for each outcome separately. We will complete a risk of bias table for each eligible study. We will discuss any disagreement amongst all authors to achieve a consensus. We presented an assessment of risk of bias using a 'Risk of bias' summary figure, which presents all of the judgments in a crosstabulation of study by entry. This display of internal validity indicates the weight the reader may give the results of each study.
We defined high quality trials as those receiving a 'low risk of bias' rating for the criterion of allocation concealment (central computerised randomisation service or sealed opaque envelopes), and for blinding of outcome assessment.
Measures of treatment effect
For dichotomous outcomes, we calculated risk ratio (RR) plus 95% confidence intervals (CI). For continuous outcomes we calculated mean difference (MD) plus 95% confidence intervals.
Unit of analysis issues
Individual patients were the analytic units in all trials, so there were no unit of analysis issues.
Dealing with missing data
If there was evidence of missing data, we contacted the study authors to request the information. Where trial authors could not provide missing data, we assessed the risk of bias of the missing data and decided if the missing data were of 'low' or 'high' risk of bias according to our risk of bias criteria (Higgins 2011). Or, if data were considered to be missing at random, we analysed the available information.
Assessment of heterogeneity
We assessed heterogeneity using the Chi 2 statistic with significance being set at P < 0.10. In addition, we investigated the degree of heterogeneity by calculating the I 2 statistic (Higgins 2002). If we identified evidence of significant heterogeneity (> 50%), we explored potential sources of heterogeneity and a randomeffects approach to the analysis was undertaken. We conducted a narrative review of eligible studies where statistical synthesis of data from more than one study was not possible or considered not appropriate.
Assessment of reporting biases
We completed a 'Risk of bias' table for each eligible study and present an assessment of risk of bias using a 'Risk of bias' summary figure (Figure 1 ) which presents the judgements in a crosstabulation. This display of internal validity indicates the weight the reader may give to the results of each study. 
Data synthesis
We analysed data using Review manager software (RevMan 2011). One review author (JW) entered the data and the other author (AA) cross-checked the printout against their own data extraction forms. We calculated risk ratios (RRs) and 95% confidence intervals (CIs) for dichotomous outcomes (risk ratio is the risk of infection in the intervention group divided by the risk of infection in the control group; a risk ratio of less than one indicates fewer infections in the intervention or adhesive drape group). We calculated mean differences (MDs) and 95% CIs for continuous outcomes. Where appropriate, we pooled the results of comparable trials using a fixed-effect model, and we reported the pooled estimate together with its 95% CI. We included all eligible trials in the initial analysis and carried out preplanned sensitivity analyses to evaluate the effect of trial quality. This was done by excluding trials most susceptible to bias (based on the quality assessment): those with inadequate allocation concealment and uncertain or unblinded outcome assessment.
Subgroup analysis and investigation of heterogeneity
We had planned the following four subgroup analyses. 1. Clean surgery compared with contaminated surgery. 2. Individual compared with cluster allocation. 3. Prophylactic antibiotic compared with no prophylaxis. 4. Hair clipping compared with shaving. The only subgroup analysis that was possible, based on available data, was of clean compared with contaminated surgery. Nor was it possible to undertake a planned sensitivity analysis based on the type of material the drape was made from due to insufficient detail about the products.
Description of studies
Results of the search
For this third update, we identified 20 potentially relevant trials using the search strategy and follow-up of reference lists. None of these studies met the inclusion criteria. The initial search identified 84 possibly relevant titles, and after screening the titles we considered 19 as potentially useful. Both review authors independently retrieved abstracts or full-texts and reviewed them against the inclusion criteria. Eleven studies did not meet the inclusion criteria and we excluded them from the review. We added two further studies to the Characteristics of excluded studies table (Breitner 1986; Swenson 2008) during the updating of this review.
Included studies
From the initial search, seven RCTs (Chiu 1993; Cordtz 1989; Dewan 1987; Jackson 1971; Psaila 1977; Segal 2002; Ward 2001) met the inclusion criteria (see Characteristics of included studies). We included these seven trials of 4195 participants in the review, with individual trial sizes ranging between 141 to 1340 participants. Five of the trials compared an adhesive drape with no adhesive drape (Chiu 1993; Cordtz 1989; Jackson 1971; Psaila 1977; Ward 2001) and two compared an iodine-impregnated adhesive drape with no adhesive drape (Dewan 1987; Segal 2002) . One study was a multi-centre trial (Cordtz 1989); the remaining trials were single centre. An a priori sample size calculation, based on a 50% reduction in the infection rate, was reported in one study (Ward 2001) . Segal 2002 reported a sample size calculation based on an analysis of results of a pilot study of 120 patients, the trial was then continued, recruiting a further 64 patients. Surgical procedures included caesarean section (Cordtz 1989; Ward 2001) , general or abdominal surgery (Dewan 1987; Jackson 1971; Psaila 1977) , hip surgery (Chiu 1993) and cardiac surgery (Segal 2002) . Surgical site infection (SSI) was not defined in one study (Chiu 1993) ; the Characteristics of included studies table contains details of other definitions used.
Four trials used iodine and alcohol to prepare the operative site (Chiu 1993; Cordtz 1989; Dewan 1987; Jackson 1971) ; one used Savlon and alcoholic chlorhexidine (Psaila 1977) ; an iodophor/ alcohol water insoluble film was used in the Segal 2002 trial; and in the Ward 2001 trial, skin was swabbed with alcoholic chlorhexidine. In the Cordtz 1989 trial, participants were also randomised to have their wound re-disinfected prior to wound closure. Jackson 1971 ran a concurrent test of antibiotic spray in random cases. Prophylactic cephalosporin was given to each patient at anaesthetic induction in the Chiu 1993 trial and all patients in the Ward 2001 trial received 1g of cephazolin when the baby's cord was clamped, unless antibiotics were already being administered for therapy or prophylaxis. Antibiotic use was recorded by Cordtz 1989 and Segal 2002 but not reported by group. No information about antibiotic use was provided by other authors (Dewan 1987; Jackson 1971; Psaila 1977) .
Excluded studies
The Characteristics of excluded studies table contains reasons for excluding 13 of these studies. In summary, six were not RCTs (Breitner 1986; Duvvi 2005; Fairclough 1986; Maxwell 1969; Swenson 2008; Yoshimura 2003) , three did not report SSI rates (French 1976; Ha'eri 1983; Manncke 1984) , one did not report the number of participants in each group (Lewis 1984) and an adhesive drape was not used in the remaining three trials (Nystrom 1980; Nystrom 1984; Williams 1972) . We excluded one trial from the first review update which was waiting assessment, as it reported colonisation rates but not SSI rates (Breitner 1986 ). The new searches undertaken for the first update identified 44 new citations, none of which met the inclusion criteria. In the second update, we identified six new citations. We retrieved the full-text of one potentially relevant trial, but it was not a RCT (Swenson 2008). For the third update, we found 14 new citations, none of which met our inclusion criteria. 
Risk of bias in included studies
Random sequence generation
In all trials, the trial authors stated that participants were randomly allocated to the intervention. It was unclear how the allocation sequence was generated in three trials (Chiu 1993; Psaila 1977; Segal 2002) . In the Cordtz 1989 trial, the National Centre for Hospital Hygiene was responsible for the randomisation process; Dewan 1987 and Ward 2001 used a random number table and in the Jackson 1971 trial, a 'spin of the coin' was used.
Allocation concealment
Allocation concealment was adequate in three studies. Segal 2002 asked surgeons participating in the trial to draw the treatment allocation from a 'closed sack' at the beginning of surgery and Ward 2001 and Dewan 1987 used sealed envelopes for group allocation. In other studies the information was not available to judge (unclear), although we contacted trial authors where possible (Chiu 1993; Cordtz 1989; Jackson 1971; Psaila 1977) .
Blinding
It was impossible for surgeons to be blinded to the intervention. In the Ward 2001 and Dewan 1987 trials, outcomes were assessed by staff who were unaware of group assignment. The study investigators inspected wounds for signs of infection in the Jackson 1971 and Segal 2002 trials. In all other trials it was unclear who was responsible for assessing outcomes, and whether those who did inspect wounds for signs of infection were aware of group assignment (Chiu 1993; Cordtz 1989; Psaila 1977) .
Incomplete outcome data
One trial did not indicate the period of follow-up (Psaila 1977).
In the remaining trials, follow-up ranged between five days and six months (Characteristics of included studies table). In the Dewan 1987 trial, 46 patients (4.2%) were unable to be tracked and were excluded from the analysis. Based on reported data, follow-up appeared to be complete in all of the other included trials. However, the absence of detailed participant flow charts, or any reference to the number who started the trial and were unable to be followed up, makes assessment of rates difficult, particularly as the followup periods were lengthy in some studies, increasing the likelihood of incomplete follow-up.
Selective reporting
Results for all expected outcomes were reported in all of the trials.
Other bias
Intention-to-treat analysis
None of the trials reported group assignment violations, and so it is difficult to assess whether patient outcomes were analysed in the group to which they were assigned. None of the trials specifically reported that they used an intention-to-treat analysis.
Baseline comparability
No information was available about baseline comparability for five trials (Chiu 1993; Cordtz 1989; Jackson 1971; Psaila 1977; Segal 2002) . In the Dewan 1987 trial, the author stated that groups were similar for all risk factors but no data was presented. Ward 2001 stated that, apart from age and parity, groups were comparable at baseline but again, no data were available for comparison.
Conflict of interest
No conflict of interests issues were reported by any of the trial authors 
Effects of interventions
Primary outcome
Surgical site infection (SSI)
Five studies were included in this comparison (Cordtz 1989; Chiu 1993; Jackson 1971; Psaila 1977; Ward 2001) . These studies included 3082 participants, of whom 1556 were in the adhesive drape group and 1526 were in the no adhesive drape group. Although the studies covered a 30-year time span and included a range of different types of surgery, we did not detect any heterogeneity (I 2 = 0%). Pooling these studies (fixed-effect model) indicated significantly more SSIs in the adhesive drape group, (RR 1.23, 95% CI 1.02 to 1.48, P = 0.03, Analysis 1.1). The overall event rate was 13.7% and 11.2% in the adhesive drape group and no drape group, respectively.
Surgical site infection -by preoperative wound classification
A single trial of 921 participants analysed infection rates based on preoperative infection risk classifications (Jackson 1971). In this trial there was no significant effect of using an adhesive drape overall, although infection rates were lower for the no adhesive drape group. Results did not vary depending on baseline risk of infection: RR (overall) 1.20, 95% CI 0.86 to 1.66; RR (for clean wounds) 1.37, 95% CI 0.53 to 3.53; RR (for potentially infected wounds) 1.24, 95% CI 0.80 to 1.92; and RR (for infected wounds) 1.03, 95% CI 0.60 to 1.75 (Analysis 1.2). We have reported results from this trial as they were presented in the published paper, even though there was a minor discrepancy between results in the text and those in the tables. For example, in the text, 52 of the 448 cases in the no adhesive drape group became infected. In the table, when cases were classified as clean, potentially infected and infected, totals were 51 infections among 445 cases. Similarly in the adhesive drape group, 67 infections were reported in 473 patients in the text and 67 of 476 in the tables. Attempts to contact investigators were unsuccessful, however, using either set of results did not affect the overall level of significance for this outcome.
Secondary outcome
Length of stay
Ward 2001 was the only trial to report length of stay. The analysis was divided into two subgroups: length of stay for those with a SSI (n = 64) and those without a SSI (n = 539). In the infected subgroup, the mean length of stay in the adhesive drape group was 10.4 days (standard deviation (SD) 3.9 days), this was not statistically different from the mean length of stay in the no adhesive drape group (10.2 days, SD 3.9 days). Length of stay was much shorter among those without a SSI. In the adhesive drape group it was 5.2 days (SD 1.3 days) and also 5.2 days (SD 1.3 days) in the no adhesive drape group. We did not find any statistical difference in length of stay between the adhesive drape and no adhesive drape groups in either of these subgroups (Analysis 1.3).
None of the trials provided information about any of the other predefined secondary outcomes (mortality, cost, hospital readmissions, adverse reactions e.g. contact dermatitis, anaphylaxis), or other serious infection or infectious complication, such as septicaemia or septic shock.
Iodine-impregnated adhesive drapes compared with no adhesive drapes (Analysis:2)
Primary outcome
Surgical site infection (SSI)
Two studies compared iodine-impregnated adhesive drapes with no adhesive drapes (Dewan 1987; Segal 2002) . These studies included 1133 participants, of whom 577 were in the iodine-impregnated adhesive drape group and 536 were in the no adhesive drape group. In the absence of heterogeneity (I² = 0%) we pooled the studies. There was no significant difference in SSI rates between the two groups (RR 1.03, 95% CI 0.66 to 1.60, P = 0.89 Analysis 2.1).
A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Iodophore-impregnated adhesive drapes compared with no adhesive drapes for preventing surgical site infection 
D I S C U S S I O N
The conclusions from the original version of this review remain unchanged in this update. Although adhesive drapes are widely used in surgery to prevent surgical site infections (SSIs), the most recent recommendations for control of SSIs remains equivocal regarding the use of adhesive drapes for this purpose (Alexander 2011). Consequently, the primary focus of this review was to address the effectiveness of adhesive drapes in preventing SSI. We identified seven studies, including 4195 patients. The main finding of this review is that adhesive drapes are not associated with a reduced infection rate compared with no adhesive drapes, and appear to be associated with an increased risk of infection. The most obvious explanation for this result is that, if adequately disinfected prior to surgery, the patient's skin is unlikely to be a primary cause of SSI; so attempts to isolate the skin from the wound, using an adhesive drape, may be pointless and potentially harmful as excessive moisture under plastic drapes may encourage bacteria residing in hair follicles to migrate to the surface and multiply (Chiu 1993).
In the only trial to report on length of stay, the use of adhesive drapes did not appear to affect the duration of hospitalisation.
There was no available evidence for our other preplanned outcomes of interest; mortality, cost, hospital readmissions or adverse reactions.
Three of the trials included in the review had concurrent interventions. Segal 2002 had four arms to the study, two of which did not involve a comparison between draping methods. In the analysis, we included the two arms of the study that included a draping comparison only. We believe it is unlikely that this design would have had an impact on the outcome as patients were mutually exclusive. Similarly, in the Psaila 1977 trial, ring drapes were used in a third group. Cordtz 1989 allocated patients to four groups, adhesive drape or no adhesive drape combined with re-disinfection or no re-disinfection. Although there was a lower rate of SSI in the re-disinfection group, the reduction was similar irrespective of the type of drape used.
Studies were of variable quality with only two trials (Dewan 1987; Ward 2001) meeting our criteria for high quality (receiving an A rating for the criterion of allocation concealment and for blinding of outcome assessment). The reporting aspects of other trials were poor, making it difficult to assess study quality. However, results of all but one of the trials were in a similar direction, favouring no adhesive drapes, providing some confidence in results. Although verification remains a problem, with many older studies, where contact with authors is impossible. Only the Psaila 1977 trial had a non-significant trend favouring adhesive drapes. This was a small study of 116 participants. The authors randomly allocated patients to two groups (adhesive drape and ring drape) and then stated, "in a control group, linen towels alone were used". We included outcomes from the control group in this study as the 'no adhesive drape' group in our analysis, but it was unclear how this group was selected. We are uncertain if any publication bias affected results; we did not find any unpublished studies.
Finally, it is unclear if all of the products used in the trials were similar. Trade names of adhesive drapes have changed over the 30year time span this review covers. Whether this has led to a qualitative improvement in the product is unclear. No specific details were provided about, for example, the density of the material or its adherability. Irrespective of this, results have remained consistent over time suggesting that any improvements or changes to the product have not affected SSI rates.
A U T H O R S ' C O N C L U S I O N S
Implications for practice
Evidence from this review suggests that use of intraoperative, incisional adhesive drapes is unlikely to reduce SSI rates, and may increase them.
Implications for research
A large, high quality definite RCT may be warranted to determine whether modern adhesive drapes do prevent or reduce SSI rates. 
A C K N O W L E D G E M E N T S
C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Chiu 1993
Methods
Study 
D A T A A N D A N A L Y S E S
Searching other resources
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on: using an open random allocation schedule (e.g. a list of random numbers); assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non opaque or not sequentially numbered); alternation or rotation; date of birth; case record number; any other explicitly unconcealed procedure.
Unclear
Insufficient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not described or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
Blinding -was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following.
• No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of others unlikely to introduce bias.
High risk of bias
• No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.
Unclear
• Insufficient information to permit judgement of low or high risk of bias.
• The study did not address this outcome.
Were incomplete outcome data adequately addressed?
Low risk of bias
• No missing outcome data.
• Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias).
• Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size.
• Missing data have been imputed using appropriate methods.
High risk of bias
• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size.
• 'As-treated' analysis done with substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
• Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated, no reasons for missing data provided).
Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Any of the following.
• The study protocol is available and all of the study's prespecified (primary and secondary) outcomes that are of interest in the review have been reported in the prespecified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were prespecified (convincing text of this nature may be uncommon).
High risk of bias
• Not all of the study's prespecified primary outcomes have been reported.
• One or more primary outcome(s) is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not prespecified.
• One or more reported primary outcomes were not prespecified (unless clear justification for their reporting is provided, such as an unexpected adverse effect).
• One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into this category.
Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias.
High risk of bias
There is at least one important risk of bias. For example, the study:
• had a potential source of bias related to the specific study design used; or • had extreme baseline imbalance; or • has been claimed to have been fraudulent; or • had some other problem.
Unclear
There may be a risk of bias, but there is either:
• insufficient information to assess whether an important risk of bias exists; or • insufficient rationale or evidence that an identified problem will introduce bias.
F E E D B A C K Feedback submitted by a representative of the Association of periOperative Registered Nurses (AORN), 19 March 2013
Summary Comment: Hello, I am sending this message as a representative of the Association of periOperative Registered Nurses (AORN). We have provided a recommendation for our members based on the conclusion of a Cochrane systematic review with meta analysis. The methodology and conclusions of the researchers are being challenged. We would respectfully request a response regarding the questions posed. AORN is a nonprofit membership association that represents the professional interests of more than 160,000 perioperative nurses by providing nursing education, standards, and clinical practice resources to enable optimal outcomes for patients undergoing operative and other invasive procedures. AORN's 40,000 registered nurse members manage, teach, and practice perioperative nursing, are enrolled in nursing education, or are engaged in perioperative research. Each year, AORN publishes its Perioperative Standards and Recommended Practices. AORN's recommended practices represent what is believed to be optimal and achievable perioperative nursing practice and are based on the highest level of evidence available. The recommended practices describe excellent perioperative nursing practices, promote patient and health care worker safety, and guide policy and procedure development in surgical and invasive procedure settings. Each recommended practices document focuses on a specific question or topic. The evidence review begins with a systematic literature search conducted using the databases MEDLINE®, CINAHL®, Scopus®, and the Cochrane Database of Systematic Reviews for meta-analyses, randomized and nonrandomized trials and studies, systematic and nonsystematic reviews, and opinion documents and letters to identify articles related to the topic. The search is conducted by a medical librarian employed by AORN. As relevant studies are located, they are independently evaluated and critically appraised according to the strength and quality of the evidence using the Johns Hopkins Evidence-Based Practice Model Evidence Appraisal tools, adapted with permission for use in the AORN Authoring System™. The reviewers participate in conference calls to discuss the appraisal scores and to establish consensus. Each article or study is assigned an appraisal score as agreed on by the reviewers. The appraisal scores of individual references are noted in brackets after the citations in the references section of the RP document, as applicable.
After the studies are appraised, the collective evidence supporting each intervention within a specific recommendation is rated using the Oncology Nursing Society Putting Evidence into Practice® schema. Factors considered in review of collective evidence are the quality of research, quantity of similar studies on a given topic, and consistency of results supporting a recommendation. In our 2013 AORN "Recommended practices for sterile technique," the following recommendation was made:
• Plastic adhesive incise drapes should not be used.
In a systematic review of seven randomized, controlled studies involving 4,195 patients, researchers concluded there was no evidence to support the use of plastic adhesive incise drapes as a method for reducing infection, and that there was some evidence that infection rates may be increased when adhesive incise drapes are used. A meta-analysis of five studies included in the review, which included 3,082 participants, compared plain plastic adhesive incise drapes with no drape and showed a significantly higher number of patients developed a surgical site infection when the adhesive incise drape was used. There was no effect on surgical site infection rates according to a meta analysis of two additional studies, including 1,113 participants, which compared iodine impregnated plastic adhesive incise drapes with no drape. The researchers theorized that the patient's skin is not likely to be a primary cause of surgical site infection if it is properly disinfected, and they concluded that attempting to isolate the skin from the surgical wound is of no benefit and may create increased moisture and bacterial growth under adhesive drapes.
The following evidence was cited to support this recommendation: Webster J, Alghamdi A. Use of plastic adhesive drapes during surgery for preventing surgical site infection. Cochrane Database Syst Rev. 2011;1.
We are aware that this Cochrane review was updated in 2013, with no new studies identified and the conclusions of the researchers remaining unchanged.
According to our AORN model for individual evidence appraisal, the 2011 systematic review with meta analysis received the highest possible score for quality and strength of evidence, and the collective body of evidence was judged by consensus to be sufficient for qualification as a recommendation for practice. The AORN recommendation not to use the adhesive incise drapes has received criticism by those who claim that the Cochrane meta analysis was flawed for the following reasons: 1. Clear incise drapes and antimicrobial incise drapes were analyzed separately and have different flaws. a. All clear incise drapes were included as one entity despite the fact that not all of the products analyzed in the report are available and that the only common feature of clear incise drapes made by different manufacturers is that they are clear. Any differences in performance as a consequence of production history, adhesive, chemistry, etc., were not considered. As a result, those questioning the recommendation believe the conclusion of the researchers that the clear incise drapes raise the risk of surgical site infection is incorrect.
2. The meta analysis on iodine containing drapes failed to isolate those cases where infections are influenced by the use of such a drape, i.e., clean and clean-contaminated cases from those where the drape is not of clear value, i.e., contaminated or dirty surgery. As a result, those questioning the recommendation believe the conclusion of the researchers is conceptually flawed. a. Those questioning the recommendation believe the use of antimicrobial impregnated incise drapes is commonly restricted to surgical cases where the nominal surgical site infection rate is approximately 1%; therefore, a randomized controlled trial would require in excess of 40,000 subjects. 3. The Cochrane review contradicts the clinical literature when speculating in the discussion that skin organisms do not cause surgical site infection. 4. The statistical methods used in the antimicrobial portion of the analysis are inconsistent with the Cochrane Collaboration methodology, in that simply combining data and summing results is an inappropriate method for analysis. AORN would greatly appreciate Cochrane's review of and response to the criticisms outlined above. We have suggested that these individuals contact Cochrane directly; however, this is not likely to happen. We believe it is important for these questions to be addressed. AORN is dedicated to providing recommendations for perioperative practice that are a credible and indispensable resource to perioperative nurses and other members of the surgical team. The use of scientific evidence to support national recommendations about clinical decisions has become an expectation of perioperative health care professionals. Evidence based practice is an essential method of improving patient care by promoting decisions based on scientific evidence rather than on the opinion of the individual health care provider. Thank you so much for your swift attention to the issues expressed in this message. We look forward to hearing from you in the near future. Please do not hesitate to call or write if you have any questions or need additional clarification. I certify that I have no affiliations with or involvement in any organization or entity with a financial interest in the subject matter of my feedback.
Reply
Response by the review author Joan Webster
The limitations of this Cochrane review include: 1. The clinical studies included in the analysis were not powered to detect a reasonable difference in SSI rates. When studies are not powered to detect a difference in an outcome, the result is that even if there were a difference in SSI rate attributable to the adhesive drape, the studies would conclude that there was no difference. Adequate statistical power is critical because a false-negative result is a predictable consequence including an insufficient number of patients. For example, with a baseline SSI rate of 5% and a reasonable 20% reduction in SSI (to 4%), 18,000 subjects are needed to provide 90% power. Consider the two iodophor-impregnated drape studies included in the Cochrane review; the minimum reduction of SSI rate required to detect an inter-group difference given the number of patients actually included is shown in Table 1 . Many individual studies included in Cochrane reviews are under-powered. The strength of meta analysis is the pooling of trials which individually may be underpowered but together increase statistical power. Moreover, because reviews are updated every 2 years, Cochrane reviews ensure that evidence is cumulative. Cochrane reviewers are committed to scientific rigor and ensuring that reviews are free of any conflicts of interest. Careful peer review, including statistical review, is undertaken before any review is published.
With respect, the authors of the feedback are making the mistake of confusing internal validity with statistical power. These are completely different issues; the former concerns whether the results of the study are likely to be a true reflection of the effect of the intervention on the people in the study (or alternatively whether they reflect a bias in the design or method). Low statistical power does not introduce bias, but it reduces the precision of the estimate, so that one is less likely to detect a real treatment difference (if it exists) as statistically significant.
2. For both meta-analyses, clear and iodine-impregnated drapes, the definition of SSI was different among the studies, and the SSI data from all four wound classes was [sic] combined to determine the effect of incise drapes. This is conceptually flawed. There are four wound categories: clean, clean-contaminated, contaminated and dirty. Skin organisms are the major cause of SSI in clean and cleancontaminated surgeries ( 1) Infection, 1999 The Hospital Infection Control Practices Advisory Committee Infect Control Hosp Epidemiol. Vol 20, No. 4, pp 247 -278 ; and 2) Anderson D., Surgical Site Infections Infec Dis Clin N Am 25 (2011) 135-153) , for which an incise drape may provide benefit by way of reducing microbial contamination of the wound and helping to maintain the sterile field. On the other hand, non-skin pathogens are the primary cause of SSIs for dirty and contaminated procedures. The Cochrane review failed to distinguish among types of wound class and, to study the effect of adhesive drapes, pooled all the SSI data from all wound classes, which is conceptually flawed. 1.1, irrespective of wound category, the SSI rate was not statistically lower in the plastic drape group, in any study. 3. The clear adhesive incise drape meta-analysis pools SSI data from five studies that used a wide variety of clear incise drapes. There was no distinction among materials, manufacturing processes, adhesives, or important study design factors. For example, two of the studies used linen or cotton drapes which are known to allow fluid and microbial strike-through, two used drapes that are no longer available, and one remarkably did not even identify the drape used (Table 2 ). In fact, the only characteristic these clear adhesive incise drapes share is their transparency. Comparability in treatment and outcome are required for valid meta-analysis -a requirement that was unmet in this case. Table 2 
This is incorrect. Please see 'Analysis 1.2 and 1.3: Adhesive drapes versus no adhesive drapes' in the updated review, which shows the surgical site infection rate by wound classification. No benefit of effect for plastic drapes was found in any category. Moreover, in Analysis
-Clear Adhesive Incise Drapes
If there are covariates which are prognostic, related to the outcome variable, it is a good idea to adjust for them. This will improve the precision of estimates. This can only be done using the participant level data, so should be done by the original investigators. It is a feature of clinical trials that most of them could have been done better. If all trials were done to the highest standard, we would not need systematic reviews, but the world is not like that. The effect of not adjusting is to widen confidence intervals and increase P values. It does not invalidate or bias the trial; it makes it inefficient.
Likelihood of bias.
The critics say: "If the initial 4 studies performed between 1971 and 1989 (3480 subjects), versus those from 1993 to 2001 (826 subjects) , had errors (confounding issues or bias) in favor of no efficacy, bias would be likely."
There is no doubt that this is a true statement. This true statement does not imply that there is, in fact, any bias. As noted above, there should not be confounding in a randomised trial and failure to adjust for covariates does not produce bias. The critics also say: "The failure to provide a recorded randomization method and the lack of blinding are both well known to lead to bias." It is true that both of these are potential sources of bias. They do not necessarily lead to bias. General experience is that biases are usually in favour of the test treatment.
3. Absence of power estimates and thus the potential for type II errors. The critics say: "All seven studies in the meta-analyses were grossly underpowered and thus the ability to find a difference -if one existed -is negated, even in the meta analysis. None of the seven clinical studies included in the analyses were powered to detect a reasonable difference in SSI rates. Adequate statistical power is critical because a false-negative result is a predictable consequence of including an insufficient number of patients. For example, with a baseline SSI rate of 5% and a reasonable 20% reduction in SSI (to 4%), 18,000 subjects are needed to provide 90% power." This calculation is correct. Many, if not most, randomised clinical trials are underpowered. However, when the trials have been carried out, we should not refuse to analyse them on these grounds. Systematic review was introduced to deal with just this problem and enables us to get the maximum amount of information from the inadequate data available. Confidence intervals, the preferred method to report results from trial, do not give us a yes or no answer but a range of plausible values for the treatment effect. In this review, for adhesive drapes the risk of SSI is estimated to be between 1.02 and 1.48 times the risk without adhesive drapes, which does not include the critics' postulated 0.80, and for iodine impregnated adhesive drapes the risk of SSI is estimated to be between 0.66 and 1.60 times the risk without adhesive drapes, which does include the critics' postulated 0.80. Thus we have good evidence that adhesive drapes increase the risk of infection, though possibly only by as much as 3%, and that iodine impregnated adhesive drapes may reduce the risk of SSI by up to a third and may increase it by up to two-thirds. Significance test approaches are not as informative. The fact that a particular study could not produce a significant difference alone does not mean it is not informative and interpretable in a meta-analysis.
Heterogeneity of the study populations, definition of primary endpoint (infections) and incise drapes that seem to preclude a meta-analysis.
There is certainly clinical heterogeneity between these studies. It may be that adhesive drapes work completely differently in different surgical procedures and using different wounds definitions, to the extent that an average effect is of no interest. If that is true, we would need very large trials separately for each type of surgery and each definition of infection. Is it plausible that the effect of adhesive drapes varies so much? This would make it very difficult to know when they could be used, in the absence of these trials. But surely while we wait for them we should make the best use of what data are currently available. We could note that there is no evidence of statistical heterogeneity in SSI relative risk, though the clinical heterogeneity would certainly lead me to prefer a random effects model to be used. Using current methods, and the random effects and the fixed effect analyses will be identical. There is no statistical reason to suppose that the clinical heterogeneity produces heterogeneity of effects. 5. The broad time span of the studies included and the absence of data in over a decade make the conclusions not useful for current medical practices. The authors say: "The first study was performed 41 years ago and the last 31 years afterwards, and no studies were included for the last 11 years. This is problematic. The practices of medicine and surgery have changed greatly; infection control and quality of care have become more visible and more effective over the time span; standardized surveillance is more commonplace now. The fact that there are no studies in over a decade during which time safety has emerged as a priority and guidelines have become more common and are more detailed suggest little relevance to practice today. Furthermore, the organisms causing infections have changed over 41 years and become more antibiotic resistant, prompting some changes in perioperative prophylaxis." 
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